Search

Displaying results 4181 - 4190 of 5449 in total
  1. Drug

    Radium Ra 223 dichloride

    go.drugbank.com/drugs/DB08913
    ApprovedInvestigational

    It was first approved by the FDA in May 2013 and is currently marketed under the brand name Xofigo, which was formerly called Alpharadin.

  2. Drug

    Sincalide

    go.drugbank.com/drugs/DB09142
    Approved

    It is identified as the 8-amino acid C-terminal segment of cholecystokinin and is also known as _CCK-8_.

  3. Drug

    Bromopride

    go.drugbank.com/drugs/DB09018
    Investigational

    It is unavailable in America or the United Kingdom.

  4. Drug

    Beraprost

    go.drugbank.com/drugs/DB05229
    Investigational

    It is also being studied for use in avoiding reperfusion injury.

  5. Drug

    Reposal

    go.drugbank.com/drugs/DB13805
    Experimental

    It was used primarily in the treatment of insomnia.

  6. Drug

    LSZ-102

    go.drugbank.com/drugs/DB15362
    Investigational

    LSZ-102 is under investigation in clinical trial NCT02734615 (Phase I/Ib Trial of LSZ102 Single Agent or LSZ102 + LEE011 or LSZ102 + BYL719 in ER+ Breast Cancers).

  7. Drug

    ENTR-601-44

    go.drugbank.com/drugs/DB17836
    Investigational

    Developed by Entrada Therapeutics, it was investigated for the treatment of Duchenne muscular dystrophy.[L46641]

  8. Drug

    PAS-004

    go.drugbank.com/drugs/DB18611
    Investigational

    It is being investigated for the treatment of neurofibromatosis 1 and Noonan syndrome.

  9. Drug

    Unasnemab

    go.drugbank.com/drugs/DB18837
    Investigational

    Unasnemab is under investigation in clinical trial NCT04683848 (Study to Assess the Efficacy and Safety of MT-3921 in Subjects With Acute Traumatic Cervical Spinal Cord Injury).

  10. Drug

    Cardiopet

    go.drugbank.com/drugs/DB18913
    Investigational

    Cardiopet is under investigation in clinical trial NCT01826773 (Cardiopet as PET Imaging Agent to Assess Myocardial Perfusion and Fatty Acid Uptake in Known or Suspected CAD Subjects).